Strona główna・Stock List・Certara Inc

Certara Inc

Closed

SectorHealthcare

8.07 -1.22

Buy Sell

Overview

Share price change

24h

Current

Min

7.99

Max

8.18

Key metrics
By Trading Economics
Income	-2.9M -8.8M
Sales	3.3M 107M
P/E Sector Avg	100.714 68.51
EPS	0.09
Profit margin	-8.196
Employees	1,515
EBITDA	-16M 16M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+1.73% upside

Dividends
By Acuity
Next Earnings	5 lis 2026

Market Stats
By TradingEconomics
Market Cap	474M 1.3B
Previous open	9.29
Previous close	8.07

News Sentiment

By Acuity

50%

128 / 340 Ranking in Healthcare

Certara Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 sie 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 sie 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 sie 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4 sie 2026, 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3 sie 2026, 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31 lip 2026, 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30 lip 2026, 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29 lip 2026, 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

28 lip 2026, 18:36 UTC

Certara Inc is higher during Tuesday's session, continuing gains from Monday. The stock remains above its 20-day moving average despite an intraday pullback.

27 lip 2026, 19:07 UTC

Certara Inc shares are trading higher during Monday's session, reflecting positive momentum since Friday's close, despite no specific company news identified.

24 lip 2026, 18:02 UTC

Certara Inc shares are trading higher today, continuing gains since Thursday's close. No specific news was identified to explain the upward movement.

23 lip 2026, 20:06 UTC

Shares of Certara Inc are higher during Thursday's session, continuing a notable increase since Wednesday's close. No specific news was identified for this movement.

22 lip 2026, 20:04 UTC

Certara Inc's shares are higher during Wednesday's session, recovering from an early decline amid broader market uncertainty ahead of the Federal Reserve meeting.

20 lip 2026, 19:31 UTC

News

Certara Inc partners with NVIDIA to enhance its AI biosimulation platform. Shares are higher, reflecting positive market sentiment around the collaboration.

Peer Comparison

Price change

Certara Inc Forecast

Price Target

By TipRanks

1.73% upside

12 Months Forecast

Average 8.21 USD 1.73%

High 9 USD

Low 7 USD

Based on 9 Wall Street analysts offering 12 month price targets forCertara Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Certara Inc - Dist in the past 3 months.

Sentiment

By Acuity

128 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.